Bnp and Ntprobnp Market

Bnp and Ntprobnp Market Size By Type (Myocardial Infarction, Acute Coronary Syndrome (ACS), Congestive Heart Failure, and Others), By Location of Testing (Laboratory Testing and Point of Care Testing), Regions, Global Industry Analysis, Share, Growth, and Trends. Forecast 2023 to 2032

Base Year: 2022 Historical Data: 2019-21
  • Report ID: TBI-13398
  • Published Date: Apr, 2023
  • Pages: 238
  • Category: Healthcare
  • Format: PDF
Buy @ $4700.00 Request Sample PDF

The global Bnp and Ntprobnp market is expected to reach USD 4.8 billion by 2032, at a CAGR of 12.4% during the forecast period 2023 to 2032. North America is expected to grow the fastest during the forecast period.

Market Overview:

The heart and blood arteries create natriuretic peptides, which are proteins. Two of these proteins, N-terminal pro-b-type natriuretic peptide (NT-proBNP) and brain natriuretic peptide (BNP) can be evaluated in the blood to aid in diagnosing congestive heart failure and other medical disorders. NT-proBNP and BNP tests are frequently administered in an emergency room or hospital. These may involve taking a blood sample from a vein in the arm or doing a fast fingerstick test. The primary goal of NT-proBNP and BNP testing is to determine whether the blood levels of these proteins are within the normal range for a healthy person. These tests are typically used to diagnose health diseases, although they may also be utilised in other types of health assessments. Determining the underlying cause of symptoms is known as a diagnosis. The BNP and NT-proBNP tests are frequently used to identify whether or not a patient has heart failure. Heart failure is when the heart does not adequately pump blood to the rest of the body, but it does not imply that the heart has ceased beating. Congestive heart failure can cause various symptoms, including oedema and shortness of breath. Yet, these symptoms might be caused by multiple illnesses other than heart failure. BNP and NT-proBNP testing can determine whether a patient's symptoms are caused by heart failure or another condition.

Bnp and Ntprobnp Market Size

Get an overview of this study by requesting a free sample

Latest Development:
  • In September 2022, SRL Diagnostics launched "Heart Assure", a specialised test to forecast an individual's cardiac incident risk. A high-sensitivity troponin blood test can accurately predict cardiac damage by producing a heart health risk score.

Market Dynamics:

Drivers

Rising geriatric population- A rise in the geriatric population, which is more susceptible to various cardiovascular diseases such as stroke, heart failure, and myocardial infarction, an increase in the adoption of BNP and NTproBNP biomarkers for cardiovascular disease diagnosis, and an increase in healthcare expenditure are the factors that are expected to boost the Bnp and Ntprobnp market. For example, according to the National Center for Biotechnology Information (NCBI), heart failure will be over 20% in those over 75 in 2021. The growing geriatric population raises the use of Bnp and NTproBnp biomarkers, stimulating the expansion of the BNP and NTproBNP market.

Restraints:

Limited specificity- The BNP and NT-proBNP testing have few adverse effects as these tests may give false-positive results, and limited specificity as BNP and NTproBNP levels are not specific for heart disease and can be elevated in other conditions such as liver disease, lung disease, and renal failure, which restrains the market growth. Additionally, BNP and NT-pro-BNP levels can be altered by several factors, including age, renal function, gender, and certain drugs, all of which can impact test results. Many of these problems limit the use of Bnp and NT-pro BNP biomarkers and have a negative impact on market growth.

Opportunities:

Rising awareness of heart failure- Increased awareness of heart failure and the need for early detection and increased use of Bnp and NT-pro BNP biomarkers in diagnosing and managing heart failure are projected to drive market growth throughout the forecast period. For example, American Heart Association (AHA) Heart-Health Screening is an awareness campaign that provides information about several screening tests for cardiovascular disease detection. Increased awareness about early disease detection drives up demand for Bnp and NT-pro BNP biomarkers. Furthermore, BNP and NTproBNP biomarkers are growing since they have high sensitivity and specificity in identifying heart failure, are less expensive than other diagnostic tests such as imaging investigations and biopsies, and provide the quickest findings.

Challenges:

A decline in heart attack cases- The decrease in heart attack mortality is predicted to have a negative impact on product adoption. According to a study conducted by the American Academy of Cardiology, between 2006 and 2016, the death rate from CHD in the United States decreased by 31.8%, while the death rate from cardiovascular illnesses decreased by 18.6%. Also, a research study conducted in the United Kingdom in September 2020 found a decrease in recurrent heart attacks, but the danger of heart failure remains significant. Furthermore, the same study stated a decline in repeat attacks from 2008 to 2017, with women experiencing a more significant decrease than men.

Regional segmentation analysis:

The regions analyzed for the market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. Asia Pacific emerged as the most significant global Bnp and Ntprobnp market, with a 40.5% market revenue share in 2022.

Asia Pacific dominates the Bnp and Ntprobnp market with a 40.5% market revenue share in 2022. This can be ascribed due to the established healthcare system and the widespread use of Bnp and Ntprobnp as a tool for ailment diagnosis and prediction. The growing geriatric population necessitates using Bnp and Ntprobnp testing to diagnose illnesses such as acute myocardial infarction, which drives the demand for testing goods. The presence of essential regional companies, such as Quidel Corporation and Danaher Corporation, contributes to the market's growth.

North America is expected to witness the fastest growth during the forecast period. The region's high prevalence of cardiovascular disorders and increased spending on cardiovascular disease diagnostic research and development are projected to boost the Bnp and Ntprobnp market throughout the forecast period. According to the 2022 Heart Disease and Stroke Statistics Update Fact Sheet, a myocardial infarction is expected to occur every 40 seconds in the United States. Similarly, the CDC updated its study in September 2021, reporting that roughly 6.5 million persons in the United States aged 40 and older have peripheral arterial disease.

Asia Pacific Region Bnp and Ntprobnp Market Share in 2022 - 40.5%

 

www.thebrainyinsights.com

Check the geographical analysis of this market by requesting a free sample

Type Analysis:

The type segment is divided into myocardial infarction, acute coronary syndrome (ACS), and congestive heart failure. The myocardial infarction segment dominated the market, with a share of around 43.8% in 2022. The death (infarction) of heart muscle (myocardium) tissue brought on by ischemia, or a lack of oxygen flow to the myocardial tissue, is known as myocardial infarction (MI). It is a subtype of acute coronary syndrome that explains an abrupt or transient change in symptoms linked to heart blood flow.

Location of Testing Analysis:

The location of the testing segment is divided into laboratory testing and point-of-care testing. The point-of-care testing segment dominated the market, with a share of around 62.0% in 2022, due to the rising use and popularity of susceptible and easy-to-use POC Troponin tests. POC tests are becoming more important as the emphasis on providing practical, value-based healthcare services in the face of restricted finances grows. Furthermore, during an emergency, these tests are the first choice of medical specialists for a speedier diagnosis of the patients. The global phenomenon of the ageing population, which is on the rise, is driving demand for POC test kits for use in nursing homes and home healthcare.

List of Key Market Players:
  • Scripps Laboratories
  • Danaher Corporation
  • Siemens AG
  • Abbott Laboratories
  • Gentian Diagnostics ASA
  • Biomerieux SA
  • PerkinElmer Inc.
  • Bio-Rad Laboratories Inc.
  • Quidel Corporation
  • F Hoffman La Roche Ltd.

Report Description: 

Attribute Description
Market Size Revenue (USD Billion)
Market size value in 2022 USD 1.5 billion
Market size value in 2032 USD 4.8 billion
CAGR (2023 to 2032) 12.4%
Historical data 2019-2021
Base Year 2022
Forecast 2023-2032
Regional Segments North America, Asia Pacific, Europe, Latin America, Middle East and Africa
Segments Type, Location of Testing

Frequesntly Asked Questions

As per The Brainy Insights, the size of the bnp and ntprobnp market was valued at USD 1.5 billion in 2022 to USD 4.8 billion by 2032.

The global bnp and ntprobnp market is growing at a CAGR of 12.4% during the forecast period 2023-2032.

Asia Pacific emerged as the largest bnp and ntprobnp market.

Key players in the bnp and ntprobnp market are Scripps Laboratories, Danaher Corporation, Siemens AG, Abbott Laboratories, Gentian Diagnostics ASA, Biomerieux SA, PerkinElmer Inc., Bio-Rad Laboratories Inc., Quidel Corporation, and F Hoffman La Roche Ltd.

1. Introduction
    1.1. Objectives of the Study
    1.2. Market Definition
    1.3. Research Scope
    1.4. Currency
    1.5. Key Target Audience

2. Research Methodology and Assumptions

3. Executive Summary

4. Premium Insights
    4.1. Porter’s Five Forces Analysis
    4.2. Value Chain Analysis
    4.3. Top Investment Pockets
          4.3.1. Market Attractiveness Analysis by Type
          4.3.2. Market Attractiveness Analysis by Location of Testing
          4.3.3. Market Attractiveness Analysis by Region
    4.4. Industry Trends

5. Market Dynamics
    5.1. Market Evaluation
    5.2. Drivers
          5.2.1. Rising Geriatric Population
    5.3. Restraints
          5.3.1. Limited Specificity
    5.4. Opportunities
          5.4.1. Rising Awareness of Heart Failure
    5.5. Challenges
          5.5.1. Decline in Heart Attack Cases

6. Global Bnp and Ntprobnp Market Analysis and Forecast, By Type
    6.1. Segment Overview
    6.2. Myocardial Infarction
    6.3. Acute Coronary Syndrome (ACS)
    6.4. Congestive Heart Failure
    6.5. Others

7. Global Bnp and Ntprobnp Market Analysis and Forecast, By Location of Testing
    7.1. Segment Overview
    7.2. Laboratory Testing
    7.3. Point of Care Testing

8. Global Bnp and Ntprobnp Market Analysis and Forecast, By Regional Analysis
    8.1. Segment Overview
    8.2. North America
          8.2.1. U.S.
          8.2.2. Canada
          8.2.3. Mexico
    8.3. Europe
          8.3.1. Germany
          8.3.2. France
          8.3.3. U.K.
          8.3.4. Italy
          8.3.5. Spain
    8.4. Asia-Pacific
          8.4.1. Japan
          8.4.2. China
          8.4.3. India
    8.5. South America
          8.5.1. Brazil
    8.6. Middle East and Africa
          8.6.1. UAE
          8.6.2. South Africa

9. Global Bnp and Ntprobnp Market-Competitive Landscape
    9.1. Overview
    9.2. Market Share of Key Players in Global Bnp and Ntprobnp Market
          9.2.1. Global Company Market Share
          9.2.2. North America Company Market Share
          9.2.3. Europe Company Market Share
          9.2.4. APAC Company Market Share
    9.3. Competitive Situations and Trends
          9.3.1. Product Launches and Developments
          9.3.2. Partnerships, Collaborations, and Agreements
          9.3.3. Mergers & Acquisitions
          9.3.4. Expansions

10. Company Profiles
    10.1. Scripps Laboratories
          10.1.1. Business Overview
          10.1.2. Company Snapshot
          10.1.3. Company Market Share Analysis
          10.1.4. Company Product Portfolio
          10.1.5. Recent Developments
          10.1.6. SWOT Analysis
    10.2. Danaher Corporation
          10.2.1. Business Overview
          10.2.2. Company Snapshot
          10.2.3. Company Market Share Analysis
          10.2.4. Company Product Portfolio
          10.2.5. Recent Developments
          10.2.6. SWOT Analysis
    10.3. Siemens AG
          10.3.1. Business Overview
          10.3.2. Company Snapshot
          10.3.3. Company Market Share Analysis
          10.3.4. Company Product Portfolio
          10.3.5. Recent Developments
          10.3.6. SWOT Analysis
    10.4. Abbott Laboratories
          10.4.1. Business Overview
          10.4.2. Company Snapshot
          10.4.3. Company Market Share Analysis
          10.4.4. Company Product Portfolio
          10.4.5. Recent Developments
          10.4.6. SWOT Analysis
    10.5. Gentian Diagnostics ASA
          10.5.1. Business Overview
          10.5.2. Company Snapshot
          10.5.3. Company Market Share Analysis
          10.5.4. Company Product Portfolio
          10.5.5. Recent Developments
          10.5.6. SWOT Analysis
    10.6. Biomerieux SA
          10.6.1. Business Overview
          10.6.2. Company Snapshot
          10.6.3. Company Market Share Analysis
          10.6.4. Company Product Portfolio
          10.6.5. Recent Developments
          10.6.6. SWOT Analysis
    10.7. PerkinElmer Inc.
          10.7.1. Business Overview
          10.7.2. Company Snapshot
          10.7.3. Company Market Share Analysis
          10.7.4. Company Product Portfolio
          10.7.5. Recent Developments
          10.7.6. SWOT Analysis
    10.8. Bio-Rad Laboratories Inc.
          10.8.1. Business Overview
          10.8.2. Company Snapshot
          10.8.3. Company Market Share Analysis
          10.8.4. Company Product Portfolio
          10.8.5. Recent Developments
          10.8.6. SWOT Analysis
    10.9. Quidel Corporation
          10.9.1. Business Overview
          10.9.2. Company Snapshot
          10.9.3. Company Market Share Analysis
          10.9.4. Company Product Portfolio
          10.9.5. Recent Developments
          10.9.6. SWOT Analysis
    10.10. F Hoffman La Roche Ltd.
          10.10.1. Business Overview
          10.10.2. Company Snapshot
          10.10.3. Company Market Share Analysis
          10.10.4. Company Product Portfolio
          10.10.5. Recent Developments
          10.10.6. SWOT Analysis

List of Table

1. Global Bnp and Ntprobnp Market, By Type, 2019-2032 (USD Billion)

2. Global Myocardial Infarction, Bnp and Ntprobnp Market, By Region, 2019-2032 (USD Billion) 

3. Global Acute Coronary Syndrome (ACS), Bnp and Ntprobnp Market, By Region, 2019-2032 (USD Billion) 

4. Global Congestive Heart Failure, Bnp and Ntprobnp Market, By Region, 2019-2032 (USD Billion) 

5. Global Others, Bnp and Ntprobnp Market, By Region, 2019-2032 (USD Billion) 

6. Global Bnp and Ntprobnp Market, By Location of Testing, 2019-2032 (USD Billion)

7. Global Laboratory Testing, Bnp and Ntprobnp Market, By Region, 2019-2032 (USD Billion)

8. Global Point of Care Testing, Bnp and Ntprobnp Market, By Region, 2019-2032 (USD Billion)

9. North America Bnp and Ntprobnp Market, By Type, 2019-2032 (USD Billion)

10. North America Bnp and Ntprobnp Market, By Location of Testing, 2019-2032 (USD Billion)

11. U.S. Bnp and Ntprobnp Market, By Type, 2019-2032 (USD Billion)

12. U.S. Bnp and Ntprobnp Market, By Location of Testing, 2019-2032 (USD Billion)

13. Canada Bnp and Ntprobnp Market, By Type, 2019-2032 (USD Billion)

14. Canada Bnp and Ntprobnp Market, By Location of Testing, 2019-2032 (USD Billion)

15. Mexico Bnp and Ntprobnp Market, By Type, 2019-2032 (USD Billion)

16. Mexico Bnp and Ntprobnp Market, By Location of Testing, 2019-2032 (USD Billion)

17. Europe Bnp and Ntprobnp Market, By Type, 2019-2032 (USD Billion)

18. Europe Bnp and Ntprobnp Market, By Location of Testing, 2019-2032 (USD Billion)

19. Germany Bnp and Ntprobnp Market, By Type, 2019-2032 (USD Billion)

20. Germany Bnp and Ntprobnp Market, By Location of Testing, 2019-2032 (USD Billion)

21. France Bnp and Ntprobnp Market, By Type, 2019-2032 (USD Billion)

22. France Bnp and Ntprobnp Market, By Location of Testing, 2019-2032 (USD Billion)

23. U.K. Bnp and Ntprobnp Market, By Type, 2019-2032 (USD Billion)

24. U.K. Bnp and Ntprobnp Market, By Location of Testing, 2019-2032 (USD Billion)

25. Italy Bnp and Ntprobnp Market, By Type, 2019-2032 (USD Billion)

26. Italy Bnp and Ntprobnp Market, By Location of Testing, 2019-2032 (USD Billion)

27. Spain Bnp and Ntprobnp Market, By Type, 2019-2032 (USD Billion)

28. Spain Bnp and Ntprobnp Market, By Location of Testing, 2019-2032 (USD Billion)

29. Asia Pacific Bnp and Ntprobnp Market, By Type, 2019-2032 (USD Billion)

30. Asia Pacific Bnp and Ntprobnp Market, By Location of Testing, 2019-2032 (USD Billion)

31. Japan Bnp and Ntprobnp Market, By Type, 2019-2032 (USD Billion)

32. Japan Bnp and Ntprobnp Market, By Location of Testing, 2019-2032 (USD Billion)

33. China Bnp and Ntprobnp Market, By Type, 2019-2032 (USD Billion)

34. China Bnp and Ntprobnp Market, By Location of Testing, 2019-2032 (USD Billion)

35. India Bnp and Ntprobnp Market, By Type, 2019-2032 (USD Billion)

36. India Bnp and Ntprobnp Market, By Location of Testing, 2019-2032 (USD Billion)

37. South America Bnp and Ntprobnp Market, By Type, 2019-2032 (USD Billion)

38. South America Bnp and Ntprobnp Market, By Location of Testing, 2019-2032 (USD Billion)

39. Brazil Bnp and Ntprobnp Market, By Type, 2019-2032 (USD Billion)

40. Brazil Bnp and Ntprobnp Market, By Location of Testing, 2019-2032 (USD Billion)

41. Middle East and Africa Bnp and Ntprobnp Market, By Type, 2019-2032 (USD Billion)

42. Middle East and Africa Bnp and Ntprobnp Market, By Location of Testing, 2019-2032 (USD Billion)

43. UAE Bnp and Ntprobnp Market, By Type, 2019-2032 (USD Billion)

44. UAE Bnp and Ntprobnp Market, By Location of Testing, 2019-2032 (USD Billion)

45. South Africa Bnp and Ntprobnp Market, By Type, 2019-2032 (USD Billion)

46. South Africa Bnp and Ntprobnp Market, By Location of Testing, 2019-2032 (USD Billion)

List of Figures 

1. Global Bnp and Ntprobnp Market Segmentation

2. Global Bnp and Ntprobnp Market: Research Methodology

3. Market Size Estimation Methodology: Bottom-Up Approach

4. Market Size Estimation Methodology: Top-Down Approach

5. Data Triangulation

6. Porter’s Five Forces Analysis 

7. Value Chain Analysis 

8. Global Bnp and Ntprobnp Market Attractiveness Analysis by Type

9. Global Bnp and Ntprobnp Market Attractiveness Analysis by Location of Testing

10. Global Bnp and Ntprobnp Market Attractiveness Analysis by Region

11. Global Bnp and Ntprobnp Market: Dynamics

12. Global Bnp and Ntprobnp Market Share by Type (2023 & 2032)

13. Global Bnp and Ntprobnp Market Share by Location of Testing (2023 & 2032)

14. Global Bnp and Ntprobnp Market Share by Regions (2023 & 2032)

15. Global Bnp and Ntprobnp Market Share by Company (2022)

This study forecasts global, regional, and country revenue from 2019 to 2032. The Brainy Insights has segmented the global bnp and ntprobnp market based on the below-mentioned segments:

Global Bnp and Ntprobnp Market By Type:

  • Myocardial Infarction
  • Acute Coronary Syndrome (ACS)
  • Congestive Heart Failure
  • Others 

Global Bnp and Ntprobnp Market By Location of Testing:

  • Laboratory Testing
  • Point of Care Testing

Global Bnp and Ntprobnp Market By Region:

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
  • Asia-Pacific
    • Japan
    • China
    • India
  • South America
    • Brazil
  • Middle East and Africa  
    • UAE
    • South Africa

Methodology

Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision. 

Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.

The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.

Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:

MARKET RESEARCH PROCESS

Data Procurement:

The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.

The data procurement stage involves in data gathering and collecting through various data sources.

This stage involves in extensive research. These data sources includes:

Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:

  • The organizational databases such as D&B Hoovers, and Bloomberg that helps us to identify the competitive scenario of the key market players/organizations along with the financial information.
  • Industry/Market databases such as Statista, and Factiva provides market/industry insights and deduce certain formulations. 
  • We also have contractual agreements with various reputed data providers and third party vendors who provide information which are not limited to:
    • Import & Export Data
    • Business Trade Information
    • Usage rates of a particular product/service on certain demographics mainly focusing on the unmet prerequisites

Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.

Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.

The supply side for a domain specific market is analysed by:

  • Estimating and projecting penetration rates through analysing product attributes, availability of internal and external substitutes, followed by pricing analysis of the product.
  • Experiential assessment of year-on-year sales of the product by conducting interviews.

The demand side for the market is estimated through:

  • Evaluating the penetration level and usage rates of the product.
  • Referring to the historical data to determine the growth rate and evaluate the industry trends

In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.

Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:

  • Applying demographic along with psychographic segmentation for market evaluation
  • Determining the Micro and Macro-economic indicators for each region 
  • Examining the industry indicators prevailing in the market. 

Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:

  • Data Screening: Data screening is the process of scrutinising data/information collected from primary research for errors and amending those collected data before data integration method. The screening involves in examining raw data, identifying errors and dealing with missing data. The purpose of the data screening is to ensure data is correctly entered or not. The Brainy Insights employs objective and systematic data screening grades involving repeated cycles of quality checks, screening and suspect analysis.
  • Data Integration: Integrating multiple data streams is necessary to produce research studies that provide in-depth picture to the clients. These data streams come from multiple research studies and our in house database. After screening of the data, our analysts conduct creative integration of data sets, optimizing connections between integrated surveys and syndicated data sources. There are mainly 2 research approaches that we follow in order to integrate our data; top down approach and bottom up approach.

Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.

This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.

Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.

The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:

  • CXOs and VPs of leading companies’ specific to sector
  • Purchasing managers, technical personnel, end-users
  • Key opinion leaders such as investment bankers, and industry consultants

Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.

Some Facts About The Brainy Insights

50%

Free Customization

300+

Fortune 500 Clients

1

Free Yearly Update On Purchase Of Multi/Corporate License

900+

Companies Served Till Date